Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on July 13, 2026

Jul. 13, 2026

Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference

Indeterminate GlobeNewswire

Jul. 13, 2026

NUMERATOR CONSUMER GOODS PRICE INDEX: INFLATION ACCELERATING, PRICES UP 3.4% VS. 2025

Indeterminate GlobeNewswire

Jul. 13, 2026

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial

Indeterminate GlobeNewswire

Jul. 13, 2026

Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress

Indeterminate GlobeNewswire

Jul. 13, 2026

Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call

Indeterminate GlobeNewswire

Jul. 13, 2026

SoundHound AI Named a Leader in the 2026 Gartner® Magic Quadrant™ for Conversational AI Platforms

Indeterminate GlobeNewswire

Jul. 13, 2026

DIY Home Improvement Market Size to Hit USD 1192.01 Billion at a CAGR of 4.21% by 2034 - Report by Zion Market Research (ZMR)

Indeterminate GlobeNewswire

Jul. 13, 2026

First patient treated in Phase 2 A-TANGO trial for acute-on-chronic liver failure

Indeterminate GlobeNewswire

Jul. 13, 2026

Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care

Indeterminate GlobeNewswire

Jul. 13, 2026

Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development

Indeterminate GlobeNewswire

Jul. 13, 2026

Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors

Indeterminate GlobeNewswire

Jul. 13, 2026

Aterian Issues Urgent Call to Action: Only 285,000 Votes or 2.7% Separates Stockholders From Securing Value

Indeterminate GlobeNewswire

Jul. 13, 2026

Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp

Indeterminate GlobeNewswire

Jul. 13, 2026

Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial

Indeterminate GlobeNewswire

Jul. 13, 2026

Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026

Indeterminate GlobeNewswire

Jul. 13, 2026

Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection

Indeterminate GlobeNewswire

Jul. 13, 2026

Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio

Indeterminate GlobeNewswire

Jul. 13, 2026

Associa Awards $25,000 in Scholarships to 10 Students Through Marianna Brady, Ph.D. Scholarship Program

Indeterminate GlobeNewswire

Jul. 13, 2026

REPEAT - Grifols deaths and harm: Patient safety & options for accountability

Indeterminate GlobeNewswire

Jul. 13, 2026

Geron Announces Appointment of Chinmaya Rath as Chief Business Officer

Indeterminate GlobeNewswire